Note dell’episodio
Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue:
First oral TNFR1 inhibitor for mild-to-moderate psoriasis
Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas
Simple biomarkers predict favourable treatment response
Mogamulizumab-associated rash – new insights into pathogenesis
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448
Sito web: eadv.podbean.com

